Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank78
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-17.89M
↑ 44% vs avg
Percentile
P78
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-32.18M
Historical baseline
PeriodValueYoY Change
TTM$-17.89M+76.6%
2024$-76.58M-14.3%
2023$-67.00M-173.6%
2022$-24.49M+30.2%
2021$-35.08M+22.9%
2020$-45.50M-61.3%
2019$-28.21M-36.6%
2018$-20.65M-363.1%
2017$-4.46M-133.1%
2016$-1.91M-